In the case of SCN1A, despite being probably the single most important gene in epilepsy, both responsible for multiple epileptic syndromes and the target of several experimental gene-based therapies, little is known about its regulatory landscape (1). The gene discussed is SCN1A; the disease is epilepsy syndrome.